{
    "id": 18264,
    "fullName": "MTOR H1968Y",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MTOR H1968Y lies within TPR repeat 15 of the Mtor protein (UniProt.org). H1968Y results in constitutive activation of Mtor signaling and increased phosphorylation of p70S6K, 4Ebp1 and Akt in cell culture (PMID: 26490311).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4623,
                    "pubMedId": 26490311,
                    "title": "Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490311"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "H1968Y",
    "createDate": "02/18/2016",
    "updateDate": "02/27/2020",
    "referenceTranscriptCoordinates": {
        "id": 145233,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11128462G>A",
        "cDna": "c.5902C>T",
        "protein": "p.H1968Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4597,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY294002 inhibited proliferation of transformed human cell lines overexpressing MTOR H1968Y in culture (PMID: 26490311).",
            "molecularProfile": {
                "id": 18602,
                "profileName": "MTOR H1968Y"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4623,
                    "pubMedId": 26490311,
                    "title": "Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490311"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4601,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human cell lines overexpressing MTOR H1968Y demonstrated reduced sensitivity to Alpelisib (BYL719)-induced growth inhibition in culture (PMID: 26490311).",
            "molecularProfile": {
                "id": 18602,
                "profileName": "MTOR H1968Y"
            },
            "therapy": {
                "id": 691,
                "therapyName": "Alpelisib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4623,
                    "pubMedId": 26490311,
                    "title": "Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490311"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 4590,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD5363 inhibited proliferation of transformed human cell lines overexpressing MTOR H1968Y in culture (PMID: 26490311).",
            "molecularProfile": {
                "id": 18602,
                "profileName": "MTOR H1968Y"
            },
            "therapy": {
                "id": 655,
                "therapyName": "Capivasertib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4623,
                    "pubMedId": 26490311,
                    "title": "Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490311"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4604,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human cell lines overexpressing MTOR H1968Y demonstrated reduced sensitivity to Afinitor (everolimus)-induced growth inhibition in culture (PMID: 26490311).",
            "molecularProfile": {
                "id": 18602,
                "profileName": "MTOR H1968Y"
            },
            "therapy": {
                "id": 735,
                "therapyName": "Everolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4623,
                    "pubMedId": 26490311,
                    "title": "Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490311"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18602,
            "profileName": "MTOR H1968Y",
            "profileTreatmentApproaches": [
                {
                    "id": 7842,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "MTOR H1968Y"
                },
                {
                    "id": 7841,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR H1968Y"
                },
                {
                    "id": 7843,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR H1968Y"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145234,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11128462G>A",
            "cDna": "c.5902C>T",
            "protein": "p.H1968Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145233,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11128462G>A",
            "cDna": "c.5902C>T",
            "protein": "p.H1968Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}